Citigroup
INBX icon

Citigroup’s Inhibrx INBX Stock Holding History

Citigroup’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.2M Buy
62,516
+6,757
+12% +$501K ﹤0.01% 2099
2025
Q4 		$4.4M Buy
55,759
+50,788
+1,022% +$3.46M ﹤0.01% 2105
2025
Q3 		$167K Buy
4,971
+1,639
+49% +$40.4K ﹤0.01% 4062
2025
Q2 		$47.5K Sell
3,332
-5,177
-61% -$66.9K ﹤0.01% 4784
2025
Q1 		$119K Sell
8,509
-1,464
-15% -$19.9K ﹤0.01% 4497
2024
Q4 		$154K Buy
9,973
+673
+7% +$10.3K ﹤0.01% 4592
2024
Q3 		$146K Buy
9,300
+5,108
+122% +$71.8K ﹤0.01% 4570
2024
Q2 		$59.4K Buy
+4,192
New +$65.5K ﹤0.01% 4485

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Citigroup's INBX Position: Q1 2026 in Review

Citigroup increased its Inhibrx (INBX) stake by 12% in Q1 2026, buying an estimated $501K and bringing the position to 62,516 shares worth $4.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Citigroup first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.4M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Citigroup held 62,516 shares of Inhibrx worth $4.2M as of Q1 2026.
  • Citigroup bought 6,757 Inhibrx shares in Q1 2026, an estimated $501K.
  • Inhibrx made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2099 holding.
  • Citigroup first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Citigroup's Inhibrx position peaked at $4.4M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.